ID   DHSO_HUMAN              Reviewed;         357 AA.
AC   Q00796; B2R655; B7Z3A6; J3JZZ5; Q16682; Q9UMD6;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   23-MAR-2010, sequence version 4.
DT   07-JAN-2015, entry version 164.
DE   RecName: Full=Sorbitol dehydrogenase;
DE            EC=1.1.1.14;
DE   AltName: Full=L-iditol 2-dehydrogenase;
GN   Name=SORD;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT THR-269.
RC   TISSUE=Liver;
RX   PubMed=8088829; DOI=10.1006/geno.1994.1276;
RA   Lee F.K., Cheung M.C., Chung S.;
RT   "The human sorbitol dehydrogenase gene: cDNA cloning, sequence
RT   determination, and mapping by fluorescence in situ hybridization.";
RL   Genomics 21:354-358(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 1), AND VARIANTS
RP   LEU-239 AND THR-269.
RX   PubMed=7782086; DOI=10.1016/0888-7543(95)80082-W;
RA   Iwata T., Popescu N.C., Zimonjic D.B., Karlsson C., Hoeoeg J.-O.,
RA   Vaca G., Rodriguez I.R., Carper D.;
RT   "Structural organization of the human sorbitol dehydrogenase gene
RT   (SORD).";
RL   Genomics 26:55-62(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT THR-269.
RX   PubMed=9183016; DOI=10.1111/j.1432-1033.1997.00760.x;
RA   Carr I.M., Markham A.F., Coletta P.L.;
RT   "Identification and characterisation of a sequence related to human
RT   sorbitol dehydrogenase.";
RL   Eur. J. Biochem. 245:760-767(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), AND VARIANT
RP   THR-269.
RC   TISSUE=Brain, and Hippocampus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16572171; DOI=10.1038/nature04601;
RA   Zody M.C., Garber M., Sharpe T., Young S.K., Rowen L., O'Neill K.,
RA   Whittaker C.A., Kamal M., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Kodira C.D., Madan A., Qin S., Yang X., Abbasi N.,
RA   Abouelleil A., Arachchi H.M., Baradarani L., Birditt B., Bloom S.,
RA   Bloom T., Borowsky M.L., Burke J., Butler J., Cook A., DeArellano K.,
RA   DeCaprio D., Dorris L. III, Dors M., Eichler E.E., Engels R.,
RA   Fahey J., Fleetwood P., Friedman C., Gearin G., Hall J.L., Hensley G.,
RA   Johnson E., Jones C., Kamat A., Kaur A., Locke D.P., Madan A.,
RA   Munson G., Jaffe D.B., Lui A., Macdonald P., Mauceli E., Naylor J.W.,
RA   Nesbitt R., Nicol R., O'Leary S.B., Ratcliffe A., Rounsley S., She X.,
RA   Sneddon K.M.B., Stewart S., Sougnez C., Stone S.M., Topham K.,
RA   Vincent D., Wang S., Zimmer A.R., Birren B.W., Hood L., Lander E.S.,
RA   Nusbaum C.;
RT   "Analysis of the DNA sequence and duplication history of human
RT   chromosome 15.";
RL   Nature 440:671-675(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   THR-269.
RC   TISSUE=Brain, and Lymph;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PROTEIN SEQUENCE OF 2-357.
RC   TISSUE=Liver;
RX   PubMed=2691249; DOI=10.1111/j.1432-1033.1989.tb15240.x;
RA   Karlsson C., Maret W., Auld D.S., Hoeoeg J.-O., Joernvall H.;
RT   "Variability within mammalian sorbitol dehydrogenases. The primary
RT   structure of the human liver enzyme.";
RL   Eur. J. Biochem. 186:543-550(1989).
RN   [8]
RP   PROTEIN SEQUENCE OF 2-21.
RC   TISSUE=Platelet;
RX   PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A.,
RA   Thomas G.R., Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass
RT   spectrometric identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [9]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=16278369; DOI=10.2164/jandrol.05108;
RA   Frenette G., Thabet M., Sullivan R.;
RT   "Polyol pathway in human epididymis and semen.";
RL   J. Androl. 27:233-239(2006).
RN   [10]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS], AND CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [11]
RP   TISSUE SPECIFICITY, AND INDUCTION.
RX   PubMed=20372835;
RA   Szabo Z., Hamalainen J., Loikkanen I., Moilanen A.M., Hirvikoski P.,
RA   Vaisanen T., Paavonen T.K., Vaarala M.H.;
RT   "Sorbitol dehydrogenase expression is regulated by androgens in the
RT   human prostate.";
RL   Oncol. Rep. 23:1233-1239(2010).
RN   [12]
RP   TISSUE SPECIFICITY.
RX   PubMed=19423711; DOI=10.1074/jbc.M109.001792;
RA   Lanaspa M.A., Andres-Hernando A., Rivard C.J., Dai Y., Li N., Berl T.;
RT   "ZAC1 is up-regulated by hypertonicity and decreases sorbitol
RT   dehydrogenase expression, allowing accumulation of sorbitol in kidney
RT   cells.";
RL   J. Biol. Chem. 284:19974-19981(2009).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS), SUBUNIT, AND ZINC-BINDING
RP   SITES.
RX   PubMed=12962626; DOI=10.1016/S0969-2126(03)00167-9;
RA   Pauly T.A., Ekstrom J.L., Beebe D.A., Chrunyk B., Cunningham D.,
RA   Griffor M., Kamath A., Lee S.E., Madura R., Mcguire D., Subashi T.,
RA   Wasilko D., Watts P., Mylari B.L., Oates P.J., Adams P.D., Rath V.L.;
RT   "X-ray crystallographic and kinetic studies of human sorbitol
RT   dehydrogenase.";
RL   Structure 11:1071-1085(2003).
CC   -!- FUNCTION: Converts sorbitol to fructose. Part of the polyol
CC       pathway that plays an important role in sperm physiology. May play
CC       a role in the sperm motility by providing an energetic source for
CC       sperm. {ECO:0000250|UniProtKB:Q64442}.
CC   -!- CATALYTIC ACTIVITY: L-iditol + NAD(+) = L-sorbose + NADH.
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC         Evidence={ECO:0000269|PubMed:12962626};
CC       Note=Binds 1 zinc ion per subunit. {ECO:0000269|PubMed:12962626};
CC   -!- SUBUNIT: Homotetramer. {ECO:0000269|PubMed:12962626}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion membrane
CC       {ECO:0000250|UniProtKB:Q64442}; Peripheral membrane protein
CC       {ECO:0000250|UniProtKB:Q64442}. Cell projection, cilium, flagellum
CC       {ECO:0000250|UniProtKB:Q64442}. Note=Associated with mitochondria
CC       of the midpiece and near the plasma membrane in the principal
CC       piece of the flagellum. Also found in the epididymosome, secreted
CC       by the epididymal epithelium and that transfers proteins from the
CC       epididymal fluid to the sperm surface.
CC       {ECO:0000250|UniProtKB:Q64442}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q00796-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q00796-2; Sequence=VSP_056353, VSP_056354;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed in kidney and epithelial cells of
CC       both benign and malignant prostate tissue. Expressed in epididymis
CC       (at protein level). {ECO:0000269|PubMed:16278369,
CC       ECO:0000269|PubMed:19423711, ECO:0000269|PubMed:20372835}.
CC   -!- INDUCTION: Up-regulated by androgens and down-regulated by
CC       castration. {ECO:0000269|PubMed:20372835}.
CC   -!- MISCELLANEOUS: The polyol pathway is proposed to be involved the
CC       cellular toxicity of diabetic hyperglycemia.
CC   -!- SIMILARITY: Belongs to the zinc-containing alcohol dehydrogenase
CC       family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U07361; AAA66064.1; -; mRNA.
DR   EMBL; L29008; AAA80565.1; -; mRNA.
DR   EMBL; L29254; AAA80566.1; -; Genomic_DNA.
DR   EMBL; L29249; AAA80566.1; JOINED; Genomic_DNA.
DR   EMBL; L29250; AAA80566.1; JOINED; Genomic_DNA.
DR   EMBL; L29251; AAA80566.1; JOINED; Genomic_DNA.
DR   EMBL; L29252; AAA80566.1; JOINED; Genomic_DNA.
DR   EMBL; L29253; AAA80566.1; JOINED; Genomic_DNA.
DR   EMBL; U67243; AAB61898.1; -; Genomic_DNA.
DR   EMBL; U67236; AAB61898.1; JOINED; Genomic_DNA.
DR   EMBL; U67237; AAB61898.1; JOINED; Genomic_DNA.
DR   EMBL; U67238; AAB61898.1; JOINED; Genomic_DNA.
DR   EMBL; U67239; AAB61898.1; JOINED; Genomic_DNA.
DR   EMBL; U67240; AAB61898.1; JOINED; Genomic_DNA.
DR   EMBL; U67241; AAB61898.1; JOINED; Genomic_DNA.
DR   EMBL; U67242; AAB61898.1; JOINED; Genomic_DNA.
DR   EMBL; AK295656; BAH12142.1; -; mRNA.
DR   EMBL; AK312444; BAG35352.1; -; mRNA.
DR   EMBL; AC090888; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC091117; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC021085; AAH21085.1; -; mRNA.
DR   EMBL; BC025295; AAH25295.1; -; mRNA.
DR   CCDS; CCDS10116.1; -. [Q00796-1]
DR   PIR; A54674; A54674.
DR   RefSeq; NP_003095.2; NM_003104.5. [Q00796-1]
DR   UniGene; Hs.878; -.
DR   PDB; 1PL6; X-ray; 2.00 A; A/B/C/D=2-357.
DR   PDB; 1PL7; X-ray; 2.20 A; A/B/C/D=2-357.
DR   PDB; 1PL8; X-ray; 1.90 A; A/B/C/D=2-357.
DR   PDBsum; 1PL6; -.
DR   PDBsum; 1PL7; -.
DR   PDBsum; 1PL8; -.
DR   ProteinModelPortal; Q00796; -.
DR   SMR; Q00796; 2-357.
DR   BioGrid; 112535; 35.
DR   IntAct; Q00796; 1.
DR   MINT; MINT-5004436; -.
DR   STRING; 9606.ENSP00000267814; -.
DR   BindingDB; Q00796; -.
DR   ChEMBL; CHEMBL2275; -.
DR   PhosphoSite; Q00796; -.
DR   DMDM; 292495088; -.
DR   REPRODUCTION-2DPAGE; IPI00216057; -.
DR   MaxQB; Q00796; -.
DR   PaxDb; Q00796; -.
DR   PRIDE; Q00796; -.
DR   DNASU; 6652; -.
DR   Ensembl; ENST00000267814; ENSP00000267814; ENSG00000140263. [Q00796-1]
DR   Ensembl; ENST00000558789; ENSP00000453904; ENSG00000140263. [Q00796-2]
DR   GeneID; 6652; -.
DR   KEGG; hsa:6652; -.
DR   UCSC; uc001zul.4; human. [Q00796-1]
DR   CTD; 6652; -.
DR   GeneCards; GC15P045315; -.
DR   HGNC; HGNC:11184; SORD.
DR   HPA; HPA040260; -.
DR   HPA; HPA040621; -.
DR   MIM; 182500; gene.
DR   neXtProt; NX_Q00796; -.
DR   PharmGKB; PA36021; -.
DR   eggNOG; COG1063; -.
DR   GeneTree; ENSGT00550000074781; -.
DR   HOGENOM; HOG000294670; -.
DR   HOVERGEN; HBG005484; -.
DR   InParanoid; Q00796; -.
DR   KO; K00008; -.
DR   OMA; THVINAK; -.
DR   OrthoDB; EOG7DRJ36; -.
DR   PhylomeDB; Q00796; -.
DR   TreeFam; TF313060; -.
DR   SABIO-RK; Q00796; -.
DR   EvolutionaryTrace; Q00796; -.
DR   GeneWiki; SORD; -.
DR   GenomeRNAi; 6652; -.
DR   NextBio; 25929; -.
DR   PRO; PR:Q00796; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   Bgee; Q00796; -.
DR   CleanEx; HS_SORD; -.
DR   ExpressionAtlas; Q00796; baseline and differential.
DR   Genevestigator; Q00796; -.
DR   GO; GO:0005615; C:extracellular space; TAS:UniProtKB.
DR   GO; GO:0070062; C:extracellular vesicular exosome; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0031966; C:mitochondrial membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0031514; C:motile cilium; ISS:UniProtKB.
DR   GO; GO:0030246; F:carbohydrate binding; NAS:UniProtKB.
DR   GO; GO:0003939; F:L-iditol 2-dehydrogenase activity; IDA:UniProtKB.
DR   GO; GO:0051287; F:NAD binding; IDA:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; IDA:UniProtKB.
DR   GO; GO:0046370; P:fructose biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0006006; P:glucose metabolic process; TAS:UniProtKB.
DR   GO; GO:0051160; P:L-xylitol catabolic process; IDA:UniProtKB.
DR   GO; GO:0051164; P:L-xylitol metabolic process; IDA:UniProtKB.
DR   GO; GO:0006062; P:sorbitol catabolic process; IDA:UniProtKB.
DR   GO; GO:0030317; P:sperm motility; ISS:UniProtKB.
DR   Gene3D; 3.40.50.720; -; 1.
DR   Gene3D; 3.90.180.10; -; 1.
DR   InterPro; IPR013149; ADH_C.
DR   InterPro; IPR013154; ADH_GroES-like.
DR   InterPro; IPR002085; ADH_SF_Zn-type.
DR   InterPro; IPR002328; ADH_Zn_CS.
DR   InterPro; IPR011032; GroES-like.
DR   InterPro; IPR016040; NAD(P)-bd_dom.
DR   PANTHER; PTHR11695; PTHR11695; 1.
DR   Pfam; PF08240; ADH_N; 1.
DR   Pfam; PF00107; ADH_zinc_N; 1.
DR   SUPFAM; SSF50129; SSF50129; 1.
DR   PROSITE; PS00059; ADH_ZINC; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Cell projection;
KW   Cilium; Complete proteome; Direct protein sequencing; Flagellum;
KW   Membrane; Metal-binding; Mitochondrion; NAD; Oxidoreductase;
KW   Polymorphism; Reference proteome; Zinc.
FT   INIT_MET      1      1       Removed. {ECO:0000269|PubMed:12665801,
FT                                ECO:0000269|PubMed:19413330,
FT                                ECO:0000269|PubMed:2691249}.
FT   CHAIN         2    357       Sorbitol dehydrogenase.
FT                                /FTId=PRO_0000160817.
FT   METAL        45     45       Zinc; catalytic.
FT                                {ECO:0000269|PubMed:12962626}.
FT   METAL        70     70       Zinc; catalytic.
FT                                {ECO:0000269|PubMed:12962626}.
FT   METAL        71     71       Zinc; catalytic.
FT                                {ECO:0000269|PubMed:12962626}.
FT   BINDING      51     51       Substrate.
FT                                {ECO:0000250|UniProtKB:P07846}.
FT   BINDING     156    156       Substrate.
FT                                {ECO:0000250|UniProtKB:P07846}.
FT   BINDING     299    299       Substrate.
FT                                {ECO:0000250|UniProtKB:P07846}.
FT   BINDING     300    300       Substrate.
FT                                {ECO:0000250|UniProtKB:P07846}.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000269|PubMed:19413330,
FT                                ECO:0000269|PubMed:8088829}.
FT   VAR_SEQ      90     99       DRVAIEPGAP -> FLTMSPLRKA (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_056353.
FT   VAR_SEQ     100    356       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_056354.
FT   VARIANT     239    239       Q -> L (in dbSNP:rs55739437).
FT                                {ECO:0000269|PubMed:7782086}.
FT                                /FTId=VAR_000430.
FT   VARIANT     269    269       N -> T (in dbSNP:rs2229659).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:7782086,
FT                                ECO:0000269|PubMed:8088829,
FT                                ECO:0000269|PubMed:9183016}.
FT                                /FTId=VAR_060351.
FT   CONFLICT      5      5       Missing (in Ref. 7; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT     59     59       N -> D (in Ref. 7; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    186    186       M -> E (in Ref. 7; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    281    281       T -> S (in Ref. 7; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    289    289       I -> T (in Ref. 7; AA sequence).
FT                                {ECO:0000305}.
FT   STRAND       10     16       {ECO:0000244|PDB:1PL8}.
FT   STRAND       19     24       {ECO:0000244|PDB:1PL8}.
FT   STRAND       34     44       {ECO:0000244|PDB:1PL8}.
FT   HELIX        46     54       {ECO:0000244|PDB:1PL8}.
FT   STRAND       55     57       {ECO:0000244|PDB:1PL8}.
FT   STRAND       71     79       {ECO:0000244|PDB:1PL8}.
FT   STRAND       91     94       {ECO:0000244|PDB:1PL8}.
FT   STRAND       96     98       {ECO:0000244|PDB:1PL8}.
FT   HELIX       104    107       {ECO:0000244|PDB:1PL8}.
FT   HELIX       111    113       {ECO:0000244|PDB:1PL8}.
FT   STRAND      130    136       {ECO:0000244|PDB:1PL8}.
FT   HELIX       137    139       {ECO:0000244|PDB:1PL8}.
FT   STRAND      140    142       {ECO:0000244|PDB:1PL8}.
FT   HELIX       149    168       {ECO:0000244|PDB:1PL8}.
FT   STRAND      175    179       {ECO:0000244|PDB:1PL8}.
FT   HELIX       183    194       {ECO:0000244|PDB:1PL8}.
FT   STRAND      198    205       {ECO:0000244|PDB:1PL8}.
FT   HELIX       207    215       {ECO:0000244|PDB:1PL8}.
FT   STRAND      219    223       {ECO:0000244|PDB:1PL8}.
FT   HELIX       229    240       {ECO:0000244|PDB:1PL8}.
FT   STRAND      245    249       {ECO:0000244|PDB:1PL8}.
FT   HELIX       254    263       {ECO:0000244|PDB:1PL8}.
FT   STRAND      269    272       {ECO:0000244|PDB:1PL8}.
FT   HELIX       284    289       {ECO:0000244|PDB:1PL8}.
FT   STRAND      293    296       {ECO:0000244|PDB:1PL8}.
FT   HELIX       304    312       {ECO:0000244|PDB:1PL8}.
FT   HELIX       319    321       {ECO:0000244|PDB:1PL8}.
FT   STRAND      322    327       {ECO:0000244|PDB:1PL8}.
FT   HELIX       328    330       {ECO:0000244|PDB:1PL8}.
FT   HELIX       331    339       {ECO:0000244|PDB:1PL8}.
FT   STRAND      344    349       {ECO:0000244|PDB:1PL8}.
SQ   SEQUENCE   357 AA;  38325 MW;  FF13DDD5EBE47754 CRC64;
     MAAAAKPNNL SLVVHGPGDL RLENYPIPEP GPNEVLLRMH SVGICGSDVH YWEYGRIGNF
     IVKKPMVLGH EASGTVEKVG SSVKHLKPGD RVAIEPGAPR ENDEFCKMGR YNLSPSIFFC
     ATPPDDGNLC RFYKHNAAFC YKLPDNVTFE EGALIEPLSV GIHACRRGGV TLGHKVLVCG
     AGPIGMVTLL VAKAMGAAQV VVTDLSATRL SKAKEIGADL VLQISKESPQ EIARKVEGQL
     GCKPEVTIEC TGAEASIQAG IYATRSGGNL VLVGLGSEMT TVPLLHAAIR EVDIKGVFRY
     CNTWPVAISM LASKSVNVKP LVTHRFPLEK ALEAFETFKK GLGLKIMLKC DPSDQNP
//
